AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 52 filers reported holding AEROVATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $280 | -28.6% | 20,653 | -9.5% | 0.03% | -57.7% |
| Q2 2023 | $392 | -24.9% | 22,832 | -11.7% | 0.07% | -1.4% |
| Q1 2023 | $522 | -13.3% | 25,863 | +25.8% | 0.07% | -20.9% |
| Q4 2022 | $602 | -99.8% | 20,560 | -3.7% | 0.09% | +68.5% |
| Q3 2022 | $354,000 | -30.2% | 21,344 | -34.2% | 0.05% | -40.0% |
| Q2 2022 | $507,000 | +15.8% | 32,414 | -12.8% | 0.09% | +20.0% |
| Q4 2021 | $438,000 | -56.5% | 37,156 | -22.7% | 0.08% | -38.5% |
| Q3 2021 | $1,008,000 | – | 48,059 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 603,762 | $17,690,227 | 28.88% |
| Atlas Venture Life Science Advisors, LLC | 2,017,521 | $59,113,365 | 7.12% |
| Sofinnova Investments, Inc. | 3,758,686 | $110,129,500 | 6.54% |
| TCG Crossover Management, LLC | 1,081,274 | $31,681,328 | 5.59% |
| RA Capital Management | 8,263,982 | $242,134,673 | 4.91% |
| Cormorant Asset Management, LP | 1,957,132 | $57,344 | 3.84% |
| VR Adviser, LLC | 747,869 | $21,912,562 | 3.69% |
| Octagon Capital Advisors LP | 621,712 | $18,216,162 | 2.84% |
| GREAT POINT PARTNERS LLC | 378,522 | $11,090,695 | 2.17% |
| Ghost Tree Capital, LLC | 135,000 | $3,956,000 | 1.69% |